A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Renal Cell Carcinoma|Gastric Cancer|Metastatic Breast Cancer|Small-cell Lung Cancer|Other Solid Tumors
Interventions: DRUG: HC-5404-FU
Sponsor: HiberCell, Inc.
Collaborators: Covance